The genre continues to grow each year too, which is definitely making it harder to sift through and find a real diamond in ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research. Reading time 2 minutes Every drug has its risks, no ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown ...

Now, GLP-1s are available for weight loss, but plenty of misconceptions exist about how best to use these drugs. It may sound nice to think about taking GLP-1s and watching the numbers on your scale ...

Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which ...